Back to Search Start Over

Melanoma during fingolimod treatment for multiple sclerosis.

Authors :
Velter C
Thomas M
Cavalcanti A
Bastien M
Chochon F
Lubetzki C
Routier E
Robert C
Source :
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2019 May; Vol. 113, pp. 75-77. Date of Electronic Publication: 2019 Apr 12.
Publication Year :
2019

Subjects

Subjects :
Back
Female
Humans
Immunologic Factors therapeutic use
Melanoma immunology
Middle Aged
Natalizumab therapeutic use
Risk Factors
Skin Neoplasms immunology
Fingolimod Hydrochloride therapeutic use
Immunosuppressive Agents therapeutic use
Melanoma diagnosis
Multiple Sclerosis drug therapy
Skin Neoplasms diagnosis

Details

Language :
English
ISSN :
1879-0852
Volume :
113
Database :
MEDLINE
Journal :
European journal of cancer (Oxford, England : 1990)
Publication Type :
Report
Accession number :
30986706
Full Text :
https://doi.org/10.1016/j.ejca.2019.03.011
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details